MedTrace Logo

Efficacy and Safety of Covid-19 Vaccine in Cardiac Patients

NCT05348629 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-04-27

No results posted yet for this study

Summary

Efficacy and safety of covid-19 vaccine in Cardiac patients

Conditions

  • COVID-19 Vaccine

Sponsors & Collaborators

  • Assiut University

    collaborator OTHER

  • Mina sobhi said fam

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-06-01
Completion
2023-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05348629 on ClinicalTrials.gov